Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-G Klingemann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cytotherapy|June 18, 2013
Cellular therapy of cancer with natural killer cells-where do we stand?Hans G Klingemann
Human Antibodies|August 14, 2012
Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragmentsMarc Delcommenne, Hans-G Klingemann
Archives of Medical Research|January 22, 2004
Hematopoietic stem cell transplantation: bone marrow vs. mobilized peripheral bloodSally Arai, Hans-G Klingemann
International Journal of Hematology|February 6, 2003
Role of immunotherapy in stem cell transplantationSally Arai, Hans G Klingemann
Expert Opinion on Biological Therapy|March 11, 2005
Natural killer cells: can they be useful as adoptive immunotherapy for cancer?Sally Arai, Hans-G Klingemann
Cellular Immunology|March 31, 2004
Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemiaJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignanciesJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Heteroclitic CD33 peptide with enhanced anti-acute myeloid leukemic immunogenicityJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Cancer Immunology, Immunotherapy : CII|April 23, 2004
The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patientsGang-Ming Zou, Jeff Martinson, Wen-Yang Hu, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targetingJiri Eitler, Natalie Wotschel, Nicole Miller, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cytotherapy|June 18, 2013
Cellular therapy of cancer with natural killer cells-where do we stand?Hans G Klingemann
Human Antibodies|August 14, 2012
Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragmentsMarc Delcommenne, Hans-G Klingemann
Archives of Medical Research|January 22, 2004
Hematopoietic stem cell transplantation: bone marrow vs. mobilized peripheral bloodSally Arai, Hans-G Klingemann
International Journal of Hematology|February 6, 2003
Role of immunotherapy in stem cell transplantationSally Arai, Hans G Klingemann
Expert Opinion on Biological Therapy|March 11, 2005
Natural killer cells: can they be useful as adoptive immunotherapy for cancer?Sally Arai, Hans-G Klingemann
Cellular Immunology|March 31, 2004
Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemiaJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignanciesJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Heteroclitic CD33 peptide with enhanced anti-acute myeloid leukemic immunogenicityJooeun Bae, Jeffrey A Martinson, Hans G Klingemann
Cancer Immunology, Immunotherapy : CII|April 23, 2004
The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patientsGang-Ming Zou, Jeff Martinson, Wen-Yang Hu, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targetingJiri Eitler, Natalie Wotschel, Nicole Miller, et al.
Pageof 2